29
January
2016
|
13:48
Europe/London
Global science network launched
rubiconlogo.jpg
The University of Manchester has joined a global network, funded by the European Commission for researchers, who study diseases of tendons, cartilage and bone.
Manchester will join nine other institutions across the world as participants in the Rubicon project, under the EC’s Horizon 2020 program, coordinated by the University of L'Aquila, Italy.
Rubicon-network.org, will run for four years, aiming to increase the understanding of the diseases and to identify new therapies.
The participating institutions will also host early stage researchers from each other to improve their interdisciplinary training so they develop innovative research and create strong partnerships between the countries.
“
This network is an invaluable way for our researchers – and especially young researchers, to learn from each other and apply some of the world’s top knowledge in this area. I’m looking forward to the next four years and would like to thank all those who have worked so hard to make it happen
Professor of Biochemistry Karl Kadler
„
Professor of Biochemistry Karl Kadler, coordinates The University of Manchester’s contribution to the project.
He said: “This network is an invaluable way for our researchers – and especially young researchers, to learn from each other and apply some of the world’s top knowledge in this area.
“I’m looking forward to the next four years and would like to thank all those who have worked so hard to make it happen.”
"The work ahead will not be easy," says Rubicon Coordinator Anna Maria Teti, Professor of Histology at the Department of Biotechnological and Applied Clinical Sciences at the University of L'Aquila, “but our previous experience on a related project, completed last year, and the participation of some of the best international institutions will stand us in good stead.
"Our young researchers are excited to participate in this project and will acquire much scientific and technical knowledge ".
Notes for editors
The project involves 5 European institutions (the Universities of L'Aquila, Newcastle and Manchester, and Erasmus MC, Rotterdam and Rigshospitalet, Glostrup, Copenhagen) and 5 non-European (the University of Cape Town, ICAHN School of Medicine at Mount Sinai, New York, Anna University, Chennai and the University of Hong Kong, and the Australian Murdoch Children's Research Institute).